Senior insider sale
VP, Corp Controller and CAO at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$2.96M
81.76K shares
What this filing means
CALVIN SANDRA plans to sell 81.76K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $2.96M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/3/2026ACC: 0001193125-26-036474
Officer· VP, Corp Controller and CAO
Since Sep 2021
81.76K
Shares to sell
$2.96M
Approx. market value
4.33K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Compensation
1/31/2026
4.33KTotal acquired4.33K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2026 | Restricted Stock Unit Vesting Compensation | 4.33K | — |
| Total | 4.33K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
7.40K
Market value
$296.1K
12/24/2025
—Completed
Units to sell
2.91K
Market value
$104.8K
12/15/2025
—Completed
Units to sell
67.11K
Market value
$2.42M
11/4/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.33K
Market value
$139.2K
2/3/2026
Total
Units
81.76K
Value
$2.96M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/24/2025 | 7.40K | $296.1K | — | Completed |
12/15/2025 | 2.91K | $104.8K | — | Completed |
11/4/2025 | 67.11K | $2.42M | — | Completed |
| Planned — Approximate Date | ||||
2/3/2026 | 4.33K | $139.2K | NASDAQ | Planned |
| Total | 81.76K | $2.96M | ||